Almost Family Inc (AFAM) 30.88 $AFAM
A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals
PR Newswire - Thu Feb 12, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.34 (unch), AFAM: 30.88 (+0.37), ALNY: 95.54 (+1.67), AMAG: 41.49 (+0.23), ALQA: 6.14 (+0.09)
Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), SCAI: 32.88 (+0.12), HLS: 45.01 (+0.30), MD: 71.32 (-0.06)
InsiderInsights.com Daily Round Up 1/23/15: OPK, SWN, AFAM, RGI
InsiderInsights - at Seeking Alpha - Sun Jan 25, 3:27AM CST
RH: 86.77 (-1.55), AFAM: 30.88 (+0.37), MRD: 18.66 (+0.23), PPR: 5.37 (+0.03), JPM: 59.67 (+0.10), OPK: 13.80 (-0.28), AGRX: 8.57 (-0.41), RDI: 12.03 (unch), RSPP: 28.48 (+1.29), GRPN: 7.97 (+0.51), SWN: 27.36 (+0.51), ACN: 89.79 (+0.70), MA: 87.14 (-0.38), URI: 92.98 (+1.41), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/22/15: SWN, CBIN, OPK, RWC
InsiderInsights - at Seeking Alpha - Fri Jan 23, 8:53AM CST
AFAM: 30.88 (+0.37), SRE: 105.56 (-1.11), SHLD: 35.70 (+2.32), OWW: 11.68 (-0.04), DLPH: 78.70 (+0.64), K: 63.20 (-0.10), MDVN: 104.71 (+0.67), NOW: 77.55 (+1.60), SNCR: 43.89 (+1.06), OPK: 13.80 (-0.28), ARR: 3.13 (unch), RWC: 5.82 (+0.06), CDNA: 6.30 (-0.14), CBIN: 27.23 (+0.08), SWN: 27.36 (+0.51), PAYC: 32.37 (-0.71)
InsiderInsights.com Daily Round Up 1/16/15: WOR, EHTH, OPK, FPRX
InsiderInsights - at Seeking Alpha - Sun Jan 18, 4:49AM CST
AFAM: 30.88 (+0.37), DEI: 29.24 (-0.20), GIII: 103.56 (+0.65), WOR: 31.13 (+0.33), BBY: 39.11 (-0.08), FUND: 7.47 (+0.05), GOOG: 549.01 (+6.08), K: 63.20 (-0.10), JPM: 59.67 (+0.10), SPW: 87.37 (-2.81), OPK: 13.80 (-0.28), RWC: 5.82 (+0.06), CDNA: 6.30 (-0.14), DYN: 28.39 (+0.01), HBI: 119.12 (+1.27), PAYC: 32.37 (-0.71), EHTH: 10.91 (-0.04), FPRX: 24.63 (+0.63)
5 Stocks Insiders Are Snapping Up: Biglari, Catalyst Pharma and More
at The Street - Thu Jan 15, 11:01AM CST
Insiders usually buy their own shares because they think the stock is a bargain and has tremendous upside.
BH: 416.41 (-1.55), AFAM: 30.88 (+0.37), CPRX: 3.36 (-0.10), RM: 15.88 (+0.96), OAS: 16.84 (-0.03)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/12/15: BH, LTS, OPK, SNCR
InsiderInsights - at Seeking Alpha - Tue Jan 13, 9:51AM CST
AFAM: 30.88 (+0.37), RTN: 107.03 (-0.37), AERI: 27.91 (+0.14), MRD: 18.66 (+0.23), ADX: 14.08 (+0.11), LTS: 3.92 (-0.02), NNVC: 2.97 (-0.05), ARDX: 17.14 (+0.71), PANW: 135.27 (+2.26), CTRE: 13.46 (+0.26), PCTY: 28.59 (+0.38), BH: 416.41 (-1.55), WIW: 11.29 (unch), SNCR: 43.89 (+1.06), OPK: 13.80 (-0.28), UBA: 22.84 (-0.21), WIA: 11.49 (-0.03)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.40 (-0.18), AFAM: 30.88 (+0.37), AAC: 29.11 (+0.91), DGX: 71.68 (+0.03)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
DaVita to Merge Business Units, Advance Clinical Research - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 12:40PM CST
DaVita HealthCare Partners Inc.'s (DVA) business units ??? DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research ??? are set to merge.
AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Humana Poised on Strong Membership Gain amid Rising Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:10PM CST
On Dec 12, 2014, we issued an updated research report on Humana Inc. (HUM).
CNC: 118.18 (-0.01), ANTM: 141.05 (-0.95), AFAM: 30.88 (+0.37), HUM: 152.67 (-1.06)
United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), LHCG: 30.42 (-0.57), BIOS: 6.04 (-0.06), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
Humana Inks Deal with Metro Health to Enhance Healthcare - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 4:56PM CST
Humana Inc. (HUM) recently entered into an agreement with Metro Health, an integrated hospital and physician network operating in West Michigan.
CNC: 118.18 (-0.01), AFAM: 30.88 (+0.37), GTIV: 19.19 (-0.23), HUM: 152.67 (-1.06)
The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Gentiva's (GTIV) Inorganic Growth Strategies Look Impressive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:10PM CST
On Nov 27, 2014, we issued an updated research report on Gentiva Health Services Inc. (GTIV).
KND: 19.68 (-0.38), AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), GTIV: 19.19 (-0.23)
Why the Earnings Streak Will Continue for Almost Family (AFAM) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:03AM CST
Almost Family could be a great candidate for another beat after a solid performance in the last two quarters.
AFAM: 30.88 (+0.37)
Upgrade Alert for Almost Family (AFAM)
Comtex SmarTrend(R) - Wed Nov 19, 6:58AM CST
Almost Family (NASDAQ:AFAM) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $26.41 on volume of 27,000 shares, below average daily volume of 47,000. Almost Family share prices have moved between a 52-week high of $33.97 and a 52-week low of $19.74 and closed yesterday at 34% above that low price at $26.41 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.3% while the 200-day MA has slid 0.2%.
AFAM: 30.88 (+0.37)
Will DaVita Kidney Care Gain On Medtronic Collaboration? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:00AM CST
DaVita HealthCare Partners Inc.'s (DVA) division DaVita Kidney Care, a leading provider of kidney care services, announced a joint venture with Medtronic.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16)
A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals
PR Newswire - Thu Feb 12, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.34 (unch), AFAM: 30.88 (+0.37), ALNY: 95.54 (+1.67), AMAG: 41.49 (+0.23), ALQA: 6.14 (+0.09)
Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), SCAI: 32.88 (+0.12), HLS: 45.01 (+0.30), MD: 71.32 (-0.06)
InsiderInsights.com Daily Round Up 1/23/15: OPK, SWN, AFAM, RGI
InsiderInsights - at Seeking Alpha - Sun Jan 25, 3:27AM CST
RH: 86.77 (-1.55), AFAM: 30.88 (+0.37), MRD: 18.66 (+0.23), PPR: 5.37 (+0.03), JPM: 59.67 (+0.10), OPK: 13.80 (-0.28), AGRX: 8.57 (-0.41), RDI: 12.03 (unch), RSPP: 28.48 (+1.29), GRPN: 7.97 (+0.51), SWN: 27.36 (+0.51), ACN: 89.79 (+0.70), MA: 87.14 (-0.38), URI: 92.98 (+1.41), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/22/15: SWN, CBIN, OPK, RWC
InsiderInsights - at Seeking Alpha - Fri Jan 23, 8:53AM CST
AFAM: 30.88 (+0.37), SRE: 105.56 (-1.11), SHLD: 35.70 (+2.32), OWW: 11.68 (-0.04), DLPH: 78.70 (+0.64), K: 63.20 (-0.10), MDVN: 104.71 (+0.67), NOW: 77.55 (+1.60), SNCR: 43.89 (+1.06), OPK: 13.80 (-0.28), ARR: 3.13 (unch), RWC: 5.82 (+0.06), CDNA: 6.30 (-0.14), CBIN: 27.23 (+0.08), SWN: 27.36 (+0.51), PAYC: 32.37 (-0.71)
InsiderInsights.com Daily Round Up 1/16/15: WOR, EHTH, OPK, FPRX
InsiderInsights - at Seeking Alpha - Sun Jan 18, 4:49AM CST
AFAM: 30.88 (+0.37), DEI: 29.24 (-0.20), GIII: 103.56 (+0.65), WOR: 31.13 (+0.33), BBY: 39.11 (-0.08), FUND: 7.47 (+0.05), GOOG: 549.01 (+6.08), K: 63.20 (-0.10), JPM: 59.67 (+0.10), SPW: 87.37 (-2.81), OPK: 13.80 (-0.28), RWC: 5.82 (+0.06), CDNA: 6.30 (-0.14), DYN: 28.39 (+0.01), HBI: 119.12 (+1.27), PAYC: 32.37 (-0.71), EHTH: 10.91 (-0.04), FPRX: 24.63 (+0.63)
5 Stocks Insiders Are Snapping Up: Biglari, Catalyst Pharma and More
at The Street - Thu Jan 15, 11:01AM CST
Insiders usually buy their own shares because they think the stock is a bargain and has tremendous upside.
BH: 416.41 (-1.55), AFAM: 30.88 (+0.37), CPRX: 3.36 (-0.10), RM: 15.88 (+0.96), OAS: 16.84 (-0.03)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/12/15: BH, LTS, OPK, SNCR
InsiderInsights - at Seeking Alpha - Tue Jan 13, 9:51AM CST
AFAM: 30.88 (+0.37), RTN: 107.03 (-0.37), AERI: 27.91 (+0.14), MRD: 18.66 (+0.23), ADX: 14.08 (+0.11), LTS: 3.92 (-0.02), NNVC: 2.97 (-0.05), ARDX: 17.14 (+0.71), PANW: 135.27 (+2.26), CTRE: 13.46 (+0.26), PCTY: 28.59 (+0.38), BH: 416.41 (-1.55), WIW: 11.29 (unch), SNCR: 43.89 (+1.06), OPK: 13.80 (-0.28), UBA: 22.84 (-0.21), WIA: 11.49 (-0.03)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.40 (-0.18), AFAM: 30.88 (+0.37), AAC: 29.11 (+0.91), DGX: 71.68 (+0.03)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
DaVita to Merge Business Units, Advance Clinical Research - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 12:40PM CST
DaVita HealthCare Partners Inc.'s (DVA) business units ??? DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research ??? are set to merge.
AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Humana Poised on Strong Membership Gain amid Rising Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 5:10PM CST
On Dec 12, 2014, we issued an updated research report on Humana Inc. (HUM).
CNC: 118.18 (-0.01), ANTM: 141.05 (-0.95), AFAM: 30.88 (+0.37), HUM: 152.67 (-1.06)
United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), LHCG: 30.42 (-0.57), BIOS: 6.04 (-0.06), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
Humana Inks Deal with Metro Health to Enhance Healthcare - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 4:56PM CST
Humana Inc. (HUM) recently entered into an agreement with Metro Health, an integrated hospital and physician network operating in West Michigan.
CNC: 118.18 (-0.01), AFAM: 30.88 (+0.37), GTIV: 19.19 (-0.23), HUM: 152.67 (-1.06)
The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Gentiva's (GTIV) Inorganic Growth Strategies Look Impressive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:10PM CST
On Nov 27, 2014, we issued an updated research report on Gentiva Health Services Inc. (GTIV).
KND: 19.68 (-0.38), AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), GTIV: 19.19 (-0.23)
Why the Earnings Streak Will Continue for Almost Family (AFAM) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:03AM CST
Almost Family could be a great candidate for another beat after a solid performance in the last two quarters.
AFAM: 30.88 (+0.37)
Upgrade Alert for Almost Family (AFAM)
Comtex SmarTrend(R) - Wed Nov 19, 6:58AM CST
Almost Family (NASDAQ:AFAM) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $26.41 on volume of 27,000 shares, below average daily volume of 47,000. Almost Family share prices have moved between a 52-week high of $33.97 and a 52-week low of $19.74 and closed yesterday at 34% above that low price at $26.41 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.3% while the 200-day MA has slid 0.2%.
AFAM: 30.88 (+0.37)
Will DaVita Kidney Care Gain On Medtronic Collaboration? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:00AM CST
DaVita HealthCare Partners Inc.'s (DVA) division DaVita Kidney Care, a leading provider of kidney care services, announced a joint venture with Medtronic.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16)
